South Africa Artificial Intelligence In Drug Discovery Market Size & Outlook
Related Markets
South Africa artificial intelligence in drug discovery market highlights
- The South Africa artificial intelligence in drug discovery market generated a revenue of USD 3.9 million in 2023 and is expected to reach USD 21.1 million by 2030.
- The South Africa market is expected to grow at a CAGR of 27.2% from 2024 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic space in 2023.
- Infectious Disease is the most lucrative therapeutic space segment registering the fastest growth during the forecast period.
Artificial intelligence in drug discovery market data book summary
| Market revenue in 2023 | USD 3.9 million |
| Market revenue in 2030 | USD 21.1 million |
| Growth rate | 27.2% (CAGR from 2024 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Infectious Disease |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Other |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.3% of the global artificial intelligence in drug discovery market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa artificial intelligence in drug discovery market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 12.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence in Drug Discovery Market Scope
Artificial Intelligence in Drug Discovery Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Insitro | View profile | 101-250 | South San Francisco, California, United States, North America | http://www.insitro.com |
| Atomwise | View profile | 51-100 | San Francisco, California, United States, North America | http://www.atomwise.com |
| BioSymetrics | View profile | 11-50 | New York, New York, United States, North America | http://www.biosymetrics.com |
| Recursion Pharmaceuticals Inc Class A | View profile | 500 | 41 S Rio Grande Street, Salt Lake City,, UT, United States, 84101 | https://www.recursion.com |
| Benevolent AI | View profile | 248 | 4-8 Maple Street, London, United Kingdom, W1T 5HD | https://www.benevolent.com |
| Aitia | View profile | 51-100 | Somerville, Massachusetts, United States, North America | https://www.aitiabio.com/ |
| Insilico Medicine | View profile | 101-250 | Hong Kong, Hong Kong Island, Hong Kong, Asia | http://www.insilico.com |
| Exscientia PLC ADR | View profile | 483 | Oxford Science Park, The Schrodinger Building, Oxford, United Kingdom, OX4 4GE | https://www.exscientia.ai |
| Alphabet Inc Class A | View profile | 180895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | https://www.abc.xyz |
| International Business Machines Corp | View profile | 282200 | One New Orchard Road, Armonk, NY, United States, 10504 | http://www.ibm.com |
South Africa artificial intelligence in drug discovery market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.08% in 2023. Horizon Databook has segmented the South Africa artificial intelligence in drug discovery market based on oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious disease, other covering the revenue growth of each sub-segment from 2018 to 2030.
The growing adoption of AI platforms for reducing overall costs of drug discovery & development and enhancing results is anticipated to drive the demand for these platforms in South Africa’s drug discovery market.
The country provides lucrative opportunities in leveraging AI due to its large population and major institutional shortfalls. The use of AI in healthcare is expected to expedite the development of solutions to major problems, such as low quality of education and access to healthcare in African countries.
There are lesser governing bottlenecks on patient data secrecy in South Africa than other regions. In addition, the use of AI in pharmacogenomics can be promising due to its diverse genetic population. The use of deep learning to expedite genomics studies is achieving significant popularity.
Reasons to subscribe to South Africa artificial intelligence in drug discovery market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa artificial intelligence in drug discovery market databook
-
Our clientele includes a mix of artificial intelligence in drug discovery market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into South Africa artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa artificial intelligence in drug discovery market size, by therapeutic space, 2018-2030 (US$M)
South Africa Artificial Intelligence in Drug Discovery Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
